Neuronetics Inc

Company Profile

Neuronetics Inc had its IPO on 2018-06-28 under the ticker symbol STIM.

The company operates in the Healthcare sector and Diagnostics & Research industry. Neuronetics Inc has a staff strength of 209 employees.

Stock update

Shares of Neuronetics Inc opened at $1.52 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $1.46 - $1.52, and closed at $1.48.

This is a -2.63% slip from the previous day's closing price.

A total volume of 326,704 shares were traded at the close of the day’s session.

In the last one week, shares of Neuronetics Inc have slipped by -9.2%.

Neuronetics Inc's Key Ratios

Neuronetics Inc has a market cap of $47.06 million, indicating a price to book ratio of 2.7701 and a price to sales ratio of 3.0017.

In the last 12-months Neuronetics Inc’s revenue was $67.85 million with a gross profit of $49.72 million and an EBITDA of $-29832000. The EBITDA ratio measures Neuronetics Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Neuronetics Inc’s operating margin was -46.93% while its return on assets stood at -17.82% with a return of equity of -55%.

In Q2, Neuronetics Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 7.8%.

Neuronetics Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-1.13 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Neuronetics Inc’s profitability.

Neuronetics Inc stock is trading at a EV to sales ratio of 2.2345 and a EV to EBITDA ratio of -4.0332. Its price to sales ratio in the trailing 12-months stood at 3.0017.

Neuronetics Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$100.39 million

Total Liabilities

$15.03 million

Operating Cash Flow

$-642000.00

Capital Expenditure

$704000

Dividend Payout Ratio

0%

Neuronetics Inc ended 2024 with $100.39 million in total assets and $0 in total liabilities. Its intangible assets were valued at $100.39 million while shareholder equity stood at $45.48 million.

Neuronetics Inc ended 2024 with $513000.00 in deferred long-term liabilities, $15.03 million in other current liabilities, 288000.00 in common stock, $-361313000.00 in retained earnings and $0 in goodwill. Its cash balance stood at $45.91 million and cash and short-term investments were $46.98 million. The company’s total short-term debt was $834,000 while long-term debt stood at $36.71 million.

Neuronetics Inc’s total current assets stands at $77.68 million while long-term investments were $4.67 million and short-term investments were $1.07 million. Its net receivables were $15.12 million compared to accounts payable of $4.14 million and inventory worth $8.87 million.

In 2024, Neuronetics Inc's operating cash flow was $-642000.00 while its capital expenditure stood at $704000.

Comparatively, Neuronetics Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$1.48

52-Week High

$6.952

52-Week Low

$1.45

Analyst Target Price

$8.67

Neuronetics Inc stock is currently trading at $1.48 per share. It touched a 52-week high of $6.952 and a 52-week low of $6.952. Analysts tracking the stock have a 12-month average target price of $8.67.

Its 50-day moving average was $1.85 and 200-day moving average was $3.59 The short ratio stood at 2.44 indicating a short percent outstanding of 0%.

Around 604% of the company’s stock are held by insiders while 7311.5% are held by institutions.